These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30928823)

  • 1. Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers.
    Hoffmann U; Lu MT; Olalere D; Adami EC; Osborne MT; Ivanov A; Aluru JS; Lee S; Arifovic N; Overton ET; Fichtenbaum CJ; Aberg JA; Alston-Smith B; Klingman KL; Waclawiw M; Burdo TH; Williams KC; Zanni MV; Desvigne-Nickens P; Cooper-Arnold K; Fitch KV; Ribaudo H; Douglas PS; Grinspoon SK;
    Am Heart J; 2019 Jun; 212():1-12. PubMed ID: 30928823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial.
    Lu MT; Ribaudo H; Foldyna B; Zanni MV; Mayrhofer T; Karady J; Taron J; Fitch KV; McCallum S; Burdo TH; Paradis K; Hedgire SS; Meyersohn NM; DeFilippi C; Malvestutto CD; Sturniolo A; Diggs M; Siminski S; Bloomfield GS; Alston-Smith B; Desvigne-Nickens P; Overton ET; Currier JS; Aberg JA; Fichtenbaum CJ; Hoffmann U; Douglas PS; Grinspoon SK;
    JAMA Cardiol; 2024 Apr; 9(4):323-334. PubMed ID: 38381407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).
    Grinspoon SK; Fitch KV; Overton ET; Fichtenbaum CJ; Zanni MV; Aberg JA; Malvestutto C; Lu MT; Currier JS; Sponseller CA; Waclawiw M; Alston-Smith B; Cooper-Arnold K; Klingman KL; Desvigne-Nickens P; Hoffmann U; Ribaudo HJ; Douglas PS;
    Am Heart J; 2019 Jun; 212():23-35. PubMed ID: 30928825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention.
    Hoffmann U; Lu MT; Foldyna B; Zanni MV; Karady J; Taron J; Zhai BK; Burdo T; Fitch KV; Kileel EM; Williams K; Fichtenbaum CJ; Overton ET; Malvestutto C; Aberg J; Currier J; Sponseller CA; Melbourne K; Floris-Moore M; Van Dam C; Keefer MC; Koletar SL; Douglas PS; Ribaudo H; Mayrhofer T; Grinspoon SK;
    JAMA Netw Open; 2021 Jun; 4(6):e2114923. PubMed ID: 34185068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort.
    Foldyna B; Mayrhofer T; Zanni MV; Lyass A; Barve R; Karady J; McCallum S; Burdo TH; Fitch KV; Paradis K; Fulda ES; Diggs MR; Bloomfield GS; Malvestutto CD; Fichtenbaum CJ; Aberg JA; Currier JS; Ribaudo HJ; Hoffmann U; Lu MT; Douglas PS; Grinspoon SK
    Clin Infect Dis; 2023 Dec; 77(12):1676-1686. PubMed ID: 37439633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results.
    Budoff MJ; Muhlestein JB; Bhatt DL; Le Pa VT; May HT; Shaikh K; Shekar C; Kinninger A; Lakshmanan S; Roy SK; Tayek J; Nelson JR
    Cardiovasc Res; 2021 Mar; 117(4):1070-1077. PubMed ID: 32609331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV).
    Schnittman SR; Lu MT; Mayrhofer T; Burdo TH; Fitch KV; McCallum S; Fulda ES; Zanni MV; Foldyna B; Malvestutto C; Fichtenbaum CJ; Aberg JA; Bloomfield GS; Overton ET; Currier J; Tebas P; Sha BE; Ribaudo HJ; Flynn JM; Douglas PS; Erlandson KM; Grinspoon SK
    Clin Infect Dis; 2023 Feb; 76(3):e613-e621. PubMed ID: 35975297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-Related Cardiovascular Disease, Statins, and the REPRIEVE Trial.
    Gilbert JM; Fitch KV; Grinspoon SK
    Top Antivir Med; 2015; 23(4):146-9. PubMed ID: 26713505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leveraging a Landmark Trial of Primary Cardiovascular Disease Prevention in Human Immunodeficiency Virus: Introduction From the REPRIEVE Coprincipal Investigators.
    Grinspoon SK; Douglas PS; Hoffmann U; Ribaudo HJ
    J Infect Dis; 2020 Jul; 222(Suppl 1):S1-S7. PubMed ID: 32645161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins for primary cardiovascular disease prevention among people with HIV: emergent directions.
    Fitch KV; Fulda ES; Grinspoon SK
    Curr Opin HIV AIDS; 2022 Sep; 17(5):293-300. PubMed ID: 35938463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Muscle Density and Area With Coronary Artery Plaque and Physical Function.
    Erlandson KM; Umbleja T; Lu MT; Taron J; Ribaudo HJ; Overton ET; Presti RM; Haas DW; Sax PE; Yin MT; Zhai BK; Louis R; Upadhyay N; Eslami P; Douglas PS; Zanni MV; Fitch KV; Fulda ES; Fichtenbaum CJ; Malvestutto CD; Grinspoon SK; Brown TT
    J Acquir Immune Defic Syndr; 2023 Oct; 94(2):174-184. PubMed ID: 37368931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual coronary plaque changes on serial CT angiography: Within-patient heterogeneity, natural history, and statin effects in HIV.
    Foldyna B; Lo J; Mayrhofer T; Grinspoon SK; Hoffmann U; Lu MT
    J Cardiovasc Comput Tomogr; 2020; 14(2):144-148. PubMed ID: 31451438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic Scores and Preclinical Cardiovascular Disease in Individuals With HIV: Insights From the REPRIEVE Trial.
    Zou RS; Ruan Y; Truong B; Bhattacharya R; Lu MT; Karády J; Bernardo R; Finneran P; Hornsby W; Fitch KV; Ribaudo HJ; Zanni MV; Douglas PS; Grinspoon SK; Patel AP; Natarajan P
    J Am Heart Assoc; 2024 Apr; 13(7):e033413. PubMed ID: 38533953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV.
    Douglas PS; McCallum S; Lu MT; Umbleja T; Fitch KV; Foldyna B; Zanni MV; Fulda ES; Bloomfield GS; Fichtenbaum CJ; Overton ET; Aberg JA; Malvestutto CD; Burdo TH; Arduino RC; Ho KS; Yin MT; Ribaudo HJ; Grinspoon SK
    AIDS; 2023 Mar; 37(3):423-434. PubMed ID: 36525544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy.
    Kolossváry M; deFilippi C; Lu MT; Zanni MV; Fulda ES; Foldyna B; Ribaudo H; Mayrhofer T; Collier AC; Bloomfield GS; Fichtenbaum C; Overton ET; Aberg JA; Currier J; Fitch KV; Douglas PS; Grinspoon SK
    J Infect Dis; 2022 Nov; 226(10):1809-1822. PubMed ID: 35535576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased arterial inflammation relates to high-risk coronary plaque morphology in HIV-infected patients.
    Tawakol A; Lo J; Zanni MV; Marmarelis E; Ihenachor EJ; MacNabb M; Wai B; Hoffmann U; Abbara S; Grinspoon S
    J Acquir Immune Defic Syndr; 2014 Jun; 66(2):164-71. PubMed ID: 24828267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States.
    Zanni MV; Foldyna B; McCallum S; Burdo TH; Looby SE; Fitch KV; Fulda ES; Autissier P; Bloomfield GS; Malvestutto CD; Fichtenbaum CJ; Overton ET; Aberg JA; Erlandson KM; Campbell TB; Ellsworth GB; Sheth AN; Taiwo B; Currier JS; Hoffmann U; Lu MT; Douglas PS; Ribaudo HJ; Grinspoon SK
    Clin Infect Dis; 2023 Jan; 76(2):323-334. PubMed ID: 36101518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of statin treatment on coronary plaque progression - a serial coronary CT angiography study.
    Zeb I; Li D; Nasir K; Malpeso J; Batool A; Flores F; Dailing C; Karlsberg RP; Budoff M
    Atherosclerosis; 2013 Dec; 231(2):198-204. PubMed ID: 24267226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of statin therapy on progression of mild noncalcified coronary plaque assessed by serial coronary computed tomography angiography: A multicenter prospective study.
    Li Z; Hou Z; Yin W; Liu K; Gao Y; Xu H; Yu F; Ma Z; Yu W; Yang L; Lu B
    Am Heart J; 2016 Oct; 180():29-38. PubMed ID: 27659880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.